Concepedia

Dietrich Steinhuebel

DS

Statistics

Publications

23

Citations

1.3K

H-Index

18

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts Institute of Technology

MSD (UK) Limited (United Kingdom)

Dietrich Steinhuebel is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, chemistry, and pharmacy.

Publications per year

1998–2024

23

Publications

23

Direct Asymmetric Reductive Amination

Dietrich Steinhuebel, Yongkui Sun, Kazuhiko Matsumura et al. · Journal of the American Chemical Society · 2009 · 211 citations

Natural Sciences, Chemistry, Medicinal Chemistry +11

First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin

Karl B. Hansen, Jaume Balsells, Spencer D. Dreher et al. · Organic Process Research & Development · 2005 · 162 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

Wonsuk Chang, Michael D. Altman, Charles A. Lesburg et al. · Journal of Medicinal Chemistry · 2022 · 137 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A kinase-cGAS cascade to synthesize a therapeutic STING activator

John A. McIntosh, Zhijian Liu, Brian M. Andresen et al. · Nature · 2022 · 135 citations

Life Sciences, Molecular Biology, Pharmacology +10

Stereoselective Enol Tosylation: Preparation of Trisubstituted α,β-Unsaturated Esters

Jenny M. Baxter, Dietrich Steinhuebel, Michael Palucki et al. · Organic Letters · 2004 · 83 citations

Pharmacy, Medicinal Chemistry, Combinatorial Chemistry +7

1–5 of 23